The Swiss attorney general is eyeing the $1.2 million deal that Novartis (NVS) made with Michael Cohen, President Trump’s personal lawyer, but is not conducting any criminal probe at this time, according to a statement from the federal prosecutor.

As reported last week, Cohen approached Novartis in early 2017 to offer access to the new Trump administration. And Joe Jimenez, who was chief executive officer at the drug maker at the time, agreed to a one-year, $1.2 million contract, even though Cohen is not a registered lobbyist or an expert in health care policy.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy